The underinclusion of diverse populations in research has created an unequal distribution of risks and benefits in research for minority groups across health conditions. The rise of the COVID-19 pandemic has highlighted this, as when non-white groups had higher rates of mortality from the disease but were also underrepresented in vaccine trials. Dr. Gilmore-Bykovskyi led a report along with researchers Dr. Wilkins and Dr. Jackson proposing specific actions the biomedical scientific community can take to address these barriers. Some actions include investing in sustained, reciprocal relationships with marginalized communities, addressing exclusionary research practices, and strengthening compliance and accountability in clinical research enrollment. Read the full paper here.